Startup profile for Hippocratic AI: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Hippocratic AI funding, valuation and investors

Healthcare LLM company focused on safety-tuned models for patient-facing clinical workflows.

Keep track of Hippocratic AI

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series C

undisclosed · 2025

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$103M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

growth · Palo Alto, California

Investors in latest funding

Other: Kleiner Perkins

Sources: latest funding Last verified: 2026-07-25

Overview

Hippocratic AI builds safety-tuned large language models for patient-facing healthcare workflows — emphasizing clinical guardrails over general-purpose chatbots.

Why Hippocratic AI is interesting

Hippocratic AI is betting that healthcare needs domain-tuned, safety-first models — not general chatbots. Core to a16z’s healthcare AI allocation.

Product & use cases

Hippocratic AI builds safety-tuned LLMs for patient-facing healthcare workflows — clinical guardrails for outreach, care navigation, and non-diagnostic interactions.

  • Patient outreach and appointment reminders
  • Care navigation and pre-visit intake
  • Non-diagnostic patient-facing voice and chat agents

Key facts

  • Seed (2023): a16z Bio+Health backed $50M seed (Fierce Healthcare)
  • Series A (Mar 2024): $53M co-led by Premji Invest and General Catalyst; Kleiner Perkins in Series C (2025) (Hippocratic AI)

Funding history (newest first)

Investors in our directory

Funds linked from Hippocratic AI's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: Healthcare-specific safety tuning vs. general chatbots — $50M seed and rapid follow-on rounds signal category urgency.

Regulated patient interactions require domain-tuned models. Hippocratic's safety-first approach targets workflows where general LLMs are liability risks.

  • Nuance DAX (Microsoft) adjacent

    Clinical documentation; Hippocratic patient-facing.

  • Ambience Healthcare adjacent

    Clinical AI scribe; different workflow.

  • ChatGPT in healthcare adjacent

    General model; lacks healthcare safety certification focus.

Notable stories

  • Unusually large $50M seed (2023) for healthcare LLM safety focus (Fierce Healthcare).
  • Founded by Munjal Shah with healthcare safety as explicit design constraint.

Industries

Healthtech AI & Machine Learning

FAQs about Hippocratic AI

Practical answers founders, operators, and investors typically search for.

Safety-tuned healthcare LLMs for patient-facing workflows — outreach, care navigation, non-diagnostic interactions.
a16z (/fund/andreessen-horowitz) led $50M seed (2023). General Catalyst (/fund/general-catalyst) co-led Series A ($53M, 2024). Kleiner (/fund/kleiner-perkins) in Series C (2025).
Hippocratic builds healthcare-specific safety guardrails; ChatGPT is general-purpose.
Positioned for non-diagnostic patient-facing workflows — outreach and navigation, not diagnosis.
Series C (2025) after $50M seed and $53M Series A.
Munjal Shah founded Hippocratic AI in 2023.
Healthcare needs domain-tuned, safety-first models for regulated patient interactions.
No — remains private.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.